Menu
Your Cart

Clinical Laboratory & CRO Services (Laboratory Service)

Clinical Laboratory & CRO Services (Laboratory Service)
Secured Shopping
Best security features
Clinical Laboratory & CRO Services (Laboratory Service)

High Efficiency, Low Cost, CLIA-Certified, CAP-Accredited Clinical Laboratory Services

  • Apostle Laboratories is a CLIA-certified clinical laboratory (CLIA ID 05D2191922), accredited by College of American Pathologists (CAP Number 8830916), with clinical laboratory licenses issued by the California state government (State ID: CDF-90001457 ).
  • It is also a licensed Medical Device Manufacturer by State of California, Department of Public Health, Food and Drug Branch (license number : 120090).
  • We are located in Pleasanton (headquarters), California.
  • Apostle Laboratories is devoted to providing high-efficiency, low-cost, professional, and comprehensive clinical laboratory support for clinical trials for pharmaceuticals, medical devices, as well as providing clinical diagnostic services. Our top-notch scientist team and capabilities of providing efficient and cost-effective CRO services enables us to be your important partner in clinical trials for pharmaceuticals and medical devices in the US market.
  • Our expertise, certificates, accreditations, and experiences empower a safe, efficient, and successful registration study for our partners.
  • For more details, including case studies, visit: https://apostlelab.com
  • Cat #: A23592-SR-1.
  • Enquire for price, questions and requests?  Email: support@apostlebio.com



$1.00
A new clinical study, led by scientists from MD Anderson Cancer Center and published in Cancer Cell (journal impact factor = 50.3), shows that tumor and cfDNA methylation can be used to identify SCLC subtypes and might guide precision SCLC therapy. Apostle MiniMax cfDNA kit is one of the critical commercial assays listed in this article. Congratulations to this clinical research team. To date, the Apostle MiniMax technology has been used in 2 articles published in Nature Communications, 2 in Nature Medicine, 1 in Science Translational Medicine, 1 in PNAS, and over 60 scientific articles by over 60 international research and clinical teams in different journals.